Visible Lights Combined with Photosensitizing Compounds Are Effective against Candida albicans Biofilms

• Main Authors: Priyanka Bapat, Gurbinder Singh, Clarissa J. Nobile
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Microorganisms
• Subjects: Candida albicans; biofilms; red, green, and blue (RGB) visible lights; photodynamic therapy; photosensitizing compounds; reactive oxygen species (ROS)
• Online Access: https://www.mdpi.com/2076-2607/9/3/500

Fungal infections are increasing in prevalence worldwide, especially in immunocompromised individuals. Given the emergence of drug-resistant fungi and the fact that there are only three major classes of antifungal drugs available to treat invasive fungal infections, there is a need to develop alternative therapeutic strategies effective against fungal infections. Candida albicans is a commensal of the human microbiota that is also one of the most common fungal pathogens isolated from clinical settings. C. albicans possesses several virulence traits that contribute to its pathogenicity, including the ability to form drug-resistant biofilms, which can make C. albicans infections particularly challenging to treat. Here, we explored red, green, and blue visible lights alone and in combination with common photosensitizing compounds for their efficacies at inhibiting and disrupting C. albicans biofilms. We found that blue light inhibited biofilm formation and disrupted mature biofilms on its own and that the addition of photosensitizing compounds improved its antibiofilm potential. Red and green lights, however, inhibited biofilm formation only in combination with photosensitizing compounds but had no effects on disrupting mature biofilms. Taken together, these results suggest that photodynamic therapy may be an effective non-drug treatment for fungal biofilm infections that is worthy of further exploration.